Try Fund Library Premium
Free with a 30 day trial!
Gain access to
- Unlimited Watchlists
- Advanced Search Filtering
- Fund Comparisons
- Portfolio Scenarios
- Customizable PDF Reports
- Portfolio Rebalancer new
Ninepoint Cannabis and Alternative Health Fund Series A
Sector Equity
|
NAVPS (05-13-2026) |
$8.91 |
|---|---|
| Change |
-$0.07
(-0.77%)
|
As at April 30, 2026
As at April 30, 2026
Loading......
Legend
Compare Options
Fund Returns
Inception Return (April 11, 2017): -0.39%
| Row Heading | Return | Annualized Return | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 Mth | 3 Mth | 6 Mth | YTD | 1 Yr | 2 Yr | 3 Yr | 4 Yr | 5 Yr | 6 Yr | 7 Yr | 8 Yr | 9 Yr | 10 Yr | |
| Fund | 6.88% | 5.85% | 3.99% | -1.60% | 10.44% | -19.64% | -5.51% | -11.21% | -16.83% | -6.09% | -10.89% | -4.16% | 0.03% | - |
| Benchmark | 3.81% | 7.00% | 13.54% | 7.89% | 40.10% | 28.50% | 21.54% | 16.52% | 15.51% | 18.30% | 14.14% | 13.56% | 12.35% | 12.61% |
| Category Average | 11.53% | 6.13% | 1.65% | 6.29% | 31.67% | 17.93% | 19.11% | 14.41% | 8.69% | 13.25% | 11.96% | 12.45% | 11.99% | 13.18% |
| Category Rank | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Quartile Ranking | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Monthly Return
| Return % | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Jan | Feb | Mar | Apr |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund | -4.85% | -1.55% | 2.04% | 17.23% | -1.42% | -3.85% | -4.25% | 10.37% | -7.04% | 0.38% | -1.34% | 6.88% |
| Benchmark | 5.56% | 2.91% | 1.69% | 4.96% | 5.40% | 0.97% | 3.86% | 1.32% | 0.84% | 7.72% | -4.32% | 3.81% |
Best Monthly Return Since Inception
23.11% (August 2018)
Worst Monthly Return Since Inception
-16.39% (May 2024)
Calendar Return (%)
| Return % | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Fund | - | - | 16.79% | -6.72% | 37.72% | -6.06% | -37.61% | -6.09% | -16.65% | 1.23% |
| Benchmark | 21.08% | 9.10% | -8.89% | 22.88% | 5.60% | 25.09% | -5.84% | 11.75% | 21.65% | 31.68% |
| Category Average | -0.43% | 20.39% | 1.55% | 22.37% | 29.99% | 15.34% | -25.24% | 26.53% | 20.41% | 15.55% |
| Quartile Ranking | - | - | - | - | - | - | - | - | - | - |
| Category Rank | - | - | - | - | - | - | - | - | - | - |
Best Calendar Return (Last 10 years)
37.72% (2020)
Worst Calendar Return (Last 10 years)
-37.61% (2022)
Asset Allocation
| Name | Percent |
|---|---|
| US Equity | 56.86 |
| Canadian Equity | 27.84 |
| Cash and Equivalents | 15.30 |
Sector Allocation
| Name | Percent |
|---|---|
| Healthcare | 54.02 |
| Cash and Cash Equivalent | 15.30 |
| Consumer Services | 12.43 |
| Consumer Goods | 7.06 |
| Technology | 1.62 |
| Other | 9.57 |
Geographic Allocation
| Name | Percent |
|---|---|
| North America | 100.00 |
Top Holdings
| Name | Percent |
|---|---|
| Green Thumb Industries Inc | 17.33 |
| Trulieve Cannabis Corp | 9.14 |
| United States Dollar | 8.68 |
| Canadian Dollar | 6.62 |
| Cronos Group Inc | 6.57 |
| Leef Brands Inc | 5.85 |
| Costco Wholesale Corp | 5.37 |
| Glass House Brands Inc Cl A | 5.10 |
| Eupraxia Pharmaceuticals Inc | 4.41 |
| Johnson & Johnson | 3.48 |
Equity Style
Fixed Income Style
Risk vs Return (3 Yr)
Ninepoint Cannabis and Alternative Health Fund Series A
Median
Other - Sector Equity
3 Yr Annualized
| Standard Deviation | 24.79% | 23.20% | - |
|---|---|---|---|
| Beta | 0.31 | 0.58 | - |
| Alpha | -0.09 | -0.24 | - |
| Rsquared | 0.02% | 0.10% | - |
| Sharpe | -0.25 | -0.80 | - |
| Sortino | -0.33 | -0.99 | - |
| Treynor | -0.21 | -0.32 | - |
| Tax Efficiency | - | - | - |
| Volatility |
|
|
- |
Risk Rating
Annualized Key Ratio Period Comparison
| Key Ratio | 1 Yr | 3 Yr | 5 Yr | 10 Yr |
|---|---|---|---|---|
| Standard Deviation | 24.61% | 24.79% | 23.20% | - |
| Beta | 0.34 | 0.31 | 0.58 | - |
| Alpha | 0.01 | -0.09 | -0.24 | - |
| Rsquared | 0.02% | 0.02% | 0.10% | - |
| Sharpe | 0.42 | -0.25 | -0.80 | - |
| Sortino | 0.86 | -0.33 | -0.99 | - |
| Treynor | 0.30 | -0.21 | -0.32 | - |
| Tax Efficiency | 100.00% | - | - | - |
Fund Details
| Start Date | April 11, 2017 |
|---|---|
| Instrument Type | Mutual Fund |
| Share Class | Do-It-Yourself |
| Legal Status | Trust |
| Sales Status | Open |
| Currency | CAD |
| Distribution Frequency | Annual |
| Assets ($mil) | - |
Fund Codes
| FundServ Code | Load Code | Sales Status |
|---|---|---|
| NPP5420 |
Investment Objectives
The Fund’s objective is to achieve growth by investing primarily in equity securities of companies engaged in nutrition, nutraceuticals and new forms of medicines and pharmaceutical solutions.
Investment Strategy
The Fund will primarily invest in a portfolio of companies that are listed on North American exchanges that have a business strategy focused on new and alternative health and wellness related themes that are growing in acceptance and importance in North America.
Portfolio Management
| Portfolio Manager |
Ninepoint Partners LP |
|---|---|
| Sub-Advisor |
Faircourt Asset Management Inc.
|
Management and Organization
| Fund Manager |
Ninepoint Partners LP |
|---|---|
| Custodian |
CIBC Mellon Trust Company |
| Registrar |
CIBC Mellon Global Securities Services Company |
| Distributor |
- |
Investment Minimums
| RSP Eligible | Yes |
|---|---|
| PAC Allowed | Yes |
| PAC Initial Investment | 1,000 |
| PAC Subsequent | 100 |
| SWP Allowed | Yes |
| SWP Min Balance | 0 |
| SWP Min Withdrawal | 0 |
Fees
| MER | 3.67% |
|---|---|
| Management Fee | 2.25% |
| Load | Back Fee Only |
| FE Max | 5.00% |
| DSC Max | - |
| Trailer Fee Max (FE) | 1.00% |
| Trailer Fee Max (DSC) | - |
| Trailer Fee Max (NL) | - |
| Trailer Fee Max (LL) | - |
Try Fund Library Premium
Free with a 30 day trial!
Gain access to
- Unlimited Watchlists
- Advanced Search Filtering
- Fund Comparisons
- Portfolio Scenarios
- Customizable PDF Reports
- Portfolio Rebalancer new
